Emerging small-molecule treatments for multiple sclerosis: focus on B cells [version 1; referees: 2 approved]
Multiple sclerosis (MS) is a major cause of disability in young adults. Following an unknown trigger (or triggers), the immune system attacks the myelin sheath surrounding axons, leading to progressive nerve cell death. Antibodies and small-molecule drugs directed against B cells have demonstrated g...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-03-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-245/v1 |